The global pandemic caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) virus has revealed the urgent need for accurate, rapid, and affordable
diagnostic tests for epidemic understanding and management by monitoring the population
worldwide. Though current diagnostic methods including real-time polymerase chain
reaction (RT-PCR) provide sensitive detection of SARS-CoV-2, they require relatively
long processing time, equipped laboratory facilities, and highly skilled personnel.
Laser-scribed graphene (LSG)-based biosensing platforms have gained enormous attention
as miniaturized electrochemical systems, holding an enormous potential as point-of-care
(POC) diagnostic tools. We describe here a miniaturized LSG-based electrochemical
sensing scheme for coronavirus disease 2019 (COVID-19) diagnosis combined with
three-dimensional (3D) gold nanostructures. This electrode was modified with the
SARS-CoV-2 spike protein antibody following the proper surface modifications proved by
X-ray photoelectron spectroscopy (XPS) and scanning electron microscopy (SEM)
characterizations as well as electrochemical techniques. The system was integrated into
a handheld POC detection system operated using a custom smartphone application,
providing a user-friendly diagnostic platform due to its ease of operation,
accessibility, and systematic data management. The analytical features of the
electrochemical immunoassay were evaluated using the standard solution of S-protein in
the range of 5.0–500 ng/mL with a detection limit of 2.9 ng/mL. A clinical study
was carried out on 23 patient blood serum samples with successful COVID-19 diagnosis,
compared to the commercial RT-PCR, antibody blood test, and enzyme-linked immunosorbent
assay (ELISA) IgG and IgA test results. Our test provides faster results compared to
commercial diagnostic tools and offers a promising alternative solution for
next-generation POC applications.